本文へ移動
cccskills
無料GitHub で公開

ish-htn-pregnancy

Classify and manage hypertensive disorders of pregnancy per the 2026 ISH Global Hypertension Practice Guidelines — pre-existing vs gestational hypertension vs preeclampsia/eclampsia/HELLP, investigations, BP measurement in pregnancy, treatment thresholds and target, first-line drugs (labetalol, nifedipine, methyldopa), drugs to avoid (ACEi, ARB, renin inhibitors), severe hypertension ≥160/110, postpartum and breastfeeding drug choice, long-term follow-up, and preeclampsia prevention (aspirin, calcium). Use when a clinician asks "BP 150/100 in pregnancy what to give", "antihypertensive in pregnancy", "is ACE inhibitor safe in pregnancy", "preeclampsia management", "severe hypertension in pregnancy", "postpartum BP medicine", "safe BP drug while breastfeeding", "aspirin for preeclampsia prevention", or "gestational hypertension vs preeclampsia". Source: Stergiou GS et al, 2026 ISH Global Hypertension Practice Guidelines, J Hypertens 2026 (DOI 10.1097/HJH.0000000000004451).

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILLスター 14(GitHub 14 + cccskills 0)

実行スコア 未検証

インストール方法を見る

含まれるファイル(1)

  • SKILL.md6.0 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Hypertension in Pregnancy (ISH 2026)

Hypertension in pregnancy = BP ≥140/90 mmHg; affects 5–10% of pregnancies. Maternal risks: abruption, stroke, organ failure, DIC, eclampsia. Fetal risks: growth restriction, preterm birth, intrauterine death.


Step 1 — Classify the disorder

TypeDefinition
Pre-existing hypertensionBefore pregnancy, or diagnosed <20 weeks, persisting >12 weeks postpartum (± proteinuria)
Gestational hypertensionDevelops ≥20 weeks, no proteinuria, resolves within 12 weeks postpartum
PreeclampsiaHypertension ≥20 weeks with proteinuria or other maternal organ dysfunction or uteroplacental dysfunction
EclampsiaPreeclampsia with seizures — immediate treatment and consider prompt delivery

Preeclampsia risk factors: pre-existing hypertension, previous preeclampsia, pre-existing diabetes, CKD, nulliparity, multifetal pregnancy, autoimmune disease, assisted reproduction, obesity, maternal age >40.

Preeclampsia warning symptoms: severe headache, visual disturbance, abdominal pain, nausea/vomiting, reduced urine output, HELLP (haemolysis, elevated liver enzymes, low platelets).


Step 2 — Investigate (ESSENTIAL)

  • FBC, urinalysis, creatinine, uric acid, liver enzymes
  • Proteinuria: early pregnancy (pre-existing renal disease) and second half (preeclampsia). Positive dipstick → UACR or protein-to-creatinine ratio

Step 3 — Measure BP correctly

  • ESSENTIAL: sOBP with calibrated manual auscultatory device, or automated upper-arm device validated specifically in pregnancy and preeclampsia (stridebp.org)
  • OPTIMAL: home or ambulatory BP to detect white-coat and masked hypertension; home monitoring with pregnancy-validated devices

Step 4 — Treat by BP level (ESSENTIAL)

Target sOBP: <140/90 mmHg — but avoid BP that is too low.

sOBPAction
140–159 / 90–109Start first-line monotherapy: labetalol or long-acting nifedipine. Alternative: methyldopa (raises post-partum depression risk). Also acceptable (less data): metoprolol, bisoprolol, felodipine, nitrendipine, amlodipine, isradipine
>160/110Emergency — hospitalise. Lower BP to <160/105 within 2–3 h with IV labetalol (or nicardipine, esmolol, hydralazine, urapidil), oral methyldopa, nifedipine or nicardipine. Consider delivery (cures preeclampsia, but risk persists early postpartum)
Preeclampsia or severe hypertensionHospitalise

CONTRAINDICATED: ACE inhibitors, ARBs, direct renin inhibitors — adverse fetal and neonatal outcomes.

For severe preeclampsia, eclampsia or HELLP: SBP <160 and DBP <105 immediately with labetalol or nicardipine + magnesium sulphate (see ish-htn-emergency).


Step 5 — Postpartum and breastfeeding

  • Monitor BP daily on days 3–7 postpartum
  • Postpartum: any recommended drug except methyldopa (post-partum depression)
  • Breastfeeding: enalapril, long-acting nifedipine, amlodipine preferred; beta-blockers may be used; ARB data limited — check prescribing information

Step 6 — Long-term follow-up

Hypertensive disorders of pregnancy raise later risk of hypertension, stroke, ischaemic heart disease and CKD (and count as a CV risk factor — see ish-htn-risk-assessment-workup).

  • Counsel on future pregnancies
  • Annual BP and renal function check
  • Lifestyle changes

Step 7 — Prevent preeclampsia (ESSENTIAL)

  • Low-to-moderate intensity exercise unless contraindicated
  • Women at increased risk: aspirin 100–150 mg from weeks 12–36
  • Low dietary calcium (<600 mg/day): oral calcium ~1 g/day

Guardrails

  • Never use ACEi, ARB or renin inhibitors in pregnancy — switch before or as soon as pregnancy is known
  • Avoid methyldopa postpartum — depression risk
  • Don't over-lower BP — target <140/90 but avoid hypotension (placental perfusion)
  • ≥160/110 is an emergency — hospitalise and lower within 2–3 h
  • Use devices validated for pregnancy — many standard devices are not
  • Preeclampsia can develop without proteinuria — organ dysfunction or uteroplacental dysfunction also count
  • Start aspirin by week 12 in high-risk women, not late
  • Arrange lifelong follow-up — previous hypertensive pregnancy is a CV risk factor

Related MD2SKILL skills

  • ish-htn-emergency — severe preeclampsia/eclampsia/HELLP
  • jes-pa-pregnancy-htn-treatment — primary aldosteronism in pregnancy
  • pdm-* (diabetes in pregnancy) skills

Source

Stergiou GS, Kario K, Aristizabal D, et al. 2026 International Society of Hypertension Global Hypertension Practice Guidelines. J Hypertens. 2026;44. DOI: 10.1097/HJH.0000000000004451. Section 9.5. A separate ISH 2026 position paper on hypertension in pregnancy is cited by the guideline (DOI 10.1097/HJH.0000000000004389).

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

コメント

ログインなしで書き込めます。使ってみた感想、質問、動かなかった環境などを気軽にどうぞ。

まだコメントはありません。最初のコメントを書いてみませんか。

送信するとすぐに公開されます。メールアドレスや電話番号などの個人情報は書かないでください。URL は 2 つまでです。

0 / 1000 文字

このフォームは reCAPTCHA で保護されており、Google のプライバシーポリシーと利用規約が適用されます。

同じリポジトリのスキル

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する